Company Filing History:
Years Active: 1982-1985
Title: Innovator Spotlight: Dan Hultmark
Introduction
Dan Hultmark is a distinguished inventor based in Nacka, Sweden, known for his contributions to the field of bacteriolytic proteins. With a total of two patents to his name, Hultmark has made significant strides in enhancing the stability and functionality of these proteins, which hold great promise in various applications, particularly in pharmaceuticals.
Latest Patents
Hultmark's latest innovative contributions include his patents for a non-lysozyme highly active bacteriolytic protein. This protein is notable for its heat stability and relatively low molecular weight. The invention details a method of producing this protein through the immunization of insects against E. coli and recovering the protein from the insect. This bacteriolytic protein has the potential to be useful for extracting proteins from genetically engineered bacteria and serves as a pharmaceutical agent for inhibiting specific bacteria.
Career Highlights
Currently, Dan Hultmark is associated with Kabigen AB, a company specializing in biotechnological advancements. His work at Kabigen AB highlights his commitment to research and innovation in the field of bacteriolytic proteins, positioning the company at the forefront of biotech solutions.
Collaborations
Throughout his career, Hultmark has collaborated with esteemed colleagues, including Hakan Steiner and Torgny Rasmuson. These partnerships reflect a collaborative spirit in scientific research, contributing to the advancement of biotechnology and patentable innovations.
Conclusion
Dan Hultmark's work exemplifies the intersection of innovative thought and practical application in the realm of biotechnology. With his patents paving the way for new advancements, Hultmark continues to play a crucial role in the development of bacteriolytic proteins that could revolutionize how we approach bacterial infections and genetic engineering. His contributions promise to enhance pharmaceutical technologies and improve health outcomes in the future.